Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells

[1]  Wolfram Goessling,et al.  The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML , 2010, Science.

[2]  A. Iwama,et al.  Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. , 2010, Cell stem cell.

[3]  Kristian Helin,et al.  Polycomb group proteins: navigators of lineage pathways led astray in cancer , 2009, Nature Reviews Cancer.

[4]  E. Vellenga,et al.  Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis. , 2009, Blood.

[5]  A. Iwama,et al.  The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. , 2008, Cancer research.

[6]  Aaron R Cooper,et al.  BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression. , 2008, Cancer research.

[7]  M. van Lohuizen,et al.  Stem cell regulation by polycomb repressors: postponing commitment. , 2008, Current opinion in cell biology.

[8]  Yuri Kotliarov,et al.  Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. , 2008, Cancer cell.

[9]  O. van Tellingen,et al.  Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. , 2007, Cancer cell.

[10]  J. Melo,et al.  The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. , 2007, Blood.

[11]  J. D. Benson,et al.  Contribution of Polycomb Homologues Bmi-1 and Mel-18 to Medulloblastoma Pathogenesis , 2007, Molecular and Cellular Biology.

[12]  M. Ohtaki,et al.  Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia , 2007, Leukemia.

[13]  Zohar Yakhini,et al.  Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.

[14]  Junia V. Melo,et al.  The polycomb group BMI 1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia , 2007 .

[15]  T. Golub,et al.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.

[16]  Megan F. Cole,et al.  Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.

[17]  A. Kimura,et al.  Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis. , 2006, Blood.

[18]  A. Iwama,et al.  Diff erential impact of Ink 4 a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi 1-defi cient mice , 2006 .

[19]  A. Kispert,et al.  The T-box transcription factor Tbx15 is required for skeletal development , 2005, Mechanisms of Development.

[20]  A. Iwama,et al.  Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. , 2004, Immunity.

[21]  K. Akashi,et al.  MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. , 2004, Cancer cell.

[22]  I. Weissman,et al.  Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. , 2003, Genes & development.

[23]  T. Kitamura,et al.  Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. , 2003, Experimental hematology.

[24]  G. Sauvageau,et al.  Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.

[25]  Irving L. Weissman,et al.  Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells , 2003, Nature.

[26]  M. Barbacid,et al.  Cyclin D-dependent kinases, INK4 inhibitors and cancer. , 2002, Biochimica et biophysica acta.

[27]  R. DePinho,et al.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.